Gossamer Bio submits New Drug Application to U.S. FDA for seralutinib for the treatment of pulmonary arterial hypertension Business Wire (Press Release) 1d
Kairos pharma to present and moderate at discovery on target conference in Boston, ma Business Wire (Press Release) 1d